Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: gemcitabine|DRUG: gemcitabine
Sponsor: Eli Lilly and Company